Book a strategy callBook a call

Medical device marketing strategy: five decisions to make before any campaign

A strategy is a short list of choices your whole team can repeat. Make these five first, and the website, the trade show and the campaigns get much easier to decide.

Written by
Guillaume Viallaneix, Founder and President of MedTech MomentumGuillaume Viallaneix
Founder and President, MedTech Momentum
Revision history
APublished
BRewritten and updated
Reading time
6 minutes
Medical device team reviewing a prosthetic arm prototype at a workbench
Before any campaign, the team has to agree who the product is for and what it can prove.

A medical device marketing strategy is a set of decisions about where you will compete and how. It names the accounts you will go after first, the people at those accounts, the message you can prove, the channels that reach them and the way you will measure progress. Everything else, from the website to the booth, follows from those choices.

I first wrote this post at the end of 2024 as a list of trends for 2025. Trends age quickly. The decisions below have held for the 26 years I have worked in MedTech, so this is the version I would rather leave up.

1. Which accounts will you go after first?

Pick the segment where you can win soonest and name the accounts in it. For a device company that might be a group of hospital systems, surgery centers or distributors in specific regions. For a contract manufacturer it is a list of OEMs by name. A strategy that targets “hospitals” or “the OEM market” is too broad to act on.

At Eden Spine, our products reached 17 countries, distributed by partners including Stryker and K2M. Those were channel decisions we made early, long before the marketing material was printed.

2. Who decides at those accounts?

List the roles that have a say and what each one needs to hear. Clinicians want to know about outcomes and technique, while the hospital’s value analysis committee wants evidence and total cost. Purchasing cares about the contract and reliable supply. At an OEM buying from a manufacturer, engineers look at capability and quality, and sourcing looks at delivery and price. Your medical device marketing works only when each of them gets an answer.

3. What can you say, and what can you prove?

Write down your core claims and the evidence behind each one, then check them against your FDA clearance and your data before a designer sees them. A message you cannot substantiate gets cut at review, usually after the brochure is designed. Settle the claims first and the creative work goes faster.

The best messages are short enough for a sales rep to repeat. With Millstone Medical Outsourcing we settled on “one PO,” meaning one purchase order for work that usually takes several suppliers. Their website, their outreach and their trade show booth all come back to it.

4. Which channels, and in what order?

Choose the channels your buyers already use, then put them in order. For many device companies the message and the website come first. Outreach and LinkedIn to the named accounts follow, then the congress where you want meetings, then the follow up. Search and AI answers build slowly in the background, which is why they should start early. Our lead generation program is built around that order.

5. How will you measure progress, and when will you review it?

Pick a measure for each stage: accounts reached, conversations, meetings, evaluations and opportunities. Set the review dates in advance. Device sales cycles are long, so judge the early months on activity and conversations and the later months on pipeline.

What has changed since 2024?

Two things, and both make the five decisions more important. The first is where buyers research. Engineers, clinicians and executives now ask AI tools like ChatGPT and Perplexity which companies to consider, and those tools answer from what they can find and trust about you: your website, articles that mention you and the way others describe your company. If your accounts, message and claims are fuzzy, the answer about you will be too. You can check what AI tools say about your company at no cost.

The second is how much content teams can now produce. AI tools make drafting faster, which makes the claims decision in step 3 even more important. Every draft still has to match your clearance and your evidence before it goes out, and a written list of approved claims is what makes that check fast.

How is a medical device marketing strategy different from a marketing plan?

The strategy is the five decisions. The plan is the calendar that carries them out, with owners, dates and a budget. Our MT-7 Framework for Growth, which we built in 2016, turns the decisions into that plan. I keep the strategy itself to one page, so the whole team can read it before a meeting.

If you want a second pair of eyes on your five decisions, book a strategy call. Bring what you have, even if it is a page of notes.

Questions I get about strategy

How often should we update our marketing strategy?

Review it at least once a year and again after any big change, such as a new clearance, a new market, an acquisition or a new competitor. The decisions about accounts and claims change less often than the channels.

Who should own the marketing strategy?

The CEO and the head of sales should own it, with marketing doing the drafting. If sales does not believe in the target accounts and the message, the strategy stays on paper.

What is the difference between a marketing strategy and a go to market strategy?

A go to market strategy covers how a product reaches the market, including pricing, channels, the sales model and the launch. The marketing strategy is the part that decides who you reach and what you say. For a new device, build the two together.

Where to go from here

Guillaume Viallaneix
Guillaume ViallaneixFounder and President, MedTech Momentum

I spent 14 years on the OEM side, launching and building two MedTech companies, before I started MedTech Momentum in Orlando in 2014.

Read our story Connect on LinkedIn